269 related articles for article (PubMed ID: 25164960)
21. Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS).
Samlowski WE; Watson GA; Wang M; Rao G; Klimo P; Boucher K; Shrieve DC; Jensen RL
Cancer; 2007 May; 109(9):1855-62. PubMed ID: 17351953
[TBL] [Abstract][Full Text] [Related]
22. Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases.
Williams NL; Wuthrick EJ; Kim H; Palmer JD; Garg S; Eldredge-Hindy H; Daskalakis C; Feeney KJ; Mastrangelo MJ; Kim LJ; Sato T; Kendra KL; Olencki T; Liebner DA; Farrell CJ; Evans JJ; Judy KD; Andrews DW; Dicker AP; Werner-Wasik M; Shi W
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):22-30. PubMed ID: 28816150
[TBL] [Abstract][Full Text] [Related]
23. Metastatic melanoma: prognostic factors and survival in patients with brain metastases.
Frinton E; Tong D; Tan J; Read G; Kumar V; Kennedy S; Lim C; Board RE
J Neurooncol; 2017 Dec; 135(3):507-512. PubMed ID: 28819707
[TBL] [Abstract][Full Text] [Related]
24. Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control.
An Y; Jiang W; Kim BYS; Qian JM; Tang C; Fang P; Logan J; D'Souza NM; Haydu LE; Wang XA; Hess KR; Kluger H; Glitza IC; Mahajan A; Welsh JW; Lin SH; Yu JB; Davies MA; Hwu P; Sulman EP; Brown PD; Chiang VLS; Li J
Radiother Oncol; 2017 Oct; 125(1):80-88. PubMed ID: 28916225
[TBL] [Abstract][Full Text] [Related]
25. Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: Patterns of care and treatment outcomes.
Gabani P; Fischer-Valuck BW; Johanns TM; Hernandez-Aya LF; Keller JW; Rich KM; Kim AH; Dunn GP; Robinson CG; Chicoine MR; Huang J; Abraham CD
Radiother Oncol; 2018 Aug; 128(2):266-273. PubMed ID: 29960685
[TBL] [Abstract][Full Text] [Related]
26. Ipilimumab and radiation therapy for melanoma brain metastases.
Silk AW; Bassetti MF; West BT; Tsien CI; Lao CD
Cancer Med; 2013 Dec; 2(6):899-906. PubMed ID: 24403263
[TBL] [Abstract][Full Text] [Related]
27. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
Singh C; Qian JM; Yu JB; Chiang VL
J Neurosurg; 2019 Feb; 132(2):512-517. PubMed ID: 30771783
[TBL] [Abstract][Full Text] [Related]
28. Clinical outcomes of melanoma brain metastases treated with nivolumab and ipilimumab alone versus nivolumab and ipilimumab with stereotactic radiosurgery.
Tang JD; Mills MN; Nakashima J; Dohm AE; Khushalani NI; Forsyth PA; Vogelbaum MA; Wuthrick EJ; Yu HM; Oliver DE; Liu JKC; Ahmed KA
J Neurooncol; 2024 Feb; 166(3):431-440. PubMed ID: 38310157
[TBL] [Abstract][Full Text] [Related]
29. Outcomes after stereotactic radiosurgery of brain metastases in patients with malignant melanoma and validation of the melanoma molGPA.
Kessel KA; Deichl A; Gempt J; Meyer B; Posch C; Diehl C; Zimmer C; Combs SE
Clin Transl Oncol; 2021 Oct; 23(10):2020-2029. PubMed ID: 33993415
[TBL] [Abstract][Full Text] [Related]
30. Immunotherapy plus surgery/radiosurgery is associated with favorable survival in patients with melanoma brain metastasis.
Amaral T; Tampouri I; Eigentler T; Keim U; Klumpp B; Heinrich V; Zips D; Paulsen F; Gepfner-Tuma I; Skardelly M; Tatagiba M; Tabatabai G; Garbe C; Forschner A
Immunotherapy; 2019 Mar; 11(4):297-309. PubMed ID: 30606066
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy.
Ahmed KA; Abuodeh YA; Echevarria MI; Arrington JA; Stallworth DG; Hogue C; Naghavi AO; Kim S; Kim Y; Patel BG; Sarangkasiri S; Johnstone PA; Sahebjam S; Khushalani NI; Forsyth PA; Harrison LB; Yu M; Etame AB; Caudell JJ
Ann Oncol; 2016 Dec; 27(12):2288-2294. PubMed ID: 27637745
[TBL] [Abstract][Full Text] [Related]
32. Stereotactic radiosurgery combined with anti-PD1 for the management of melanoma brain metastases: A retrospective study of safety and efficacy.
Carron R; Gaudy-Marqueste C; Amatore F; Padovani L; Malissen N; Balossier A; Loundou A; Bonnet N; Muracciole X; Régis JM; Grob JJ
Eur J Cancer; 2020 Aug; 135():52-61. PubMed ID: 32535348
[TBL] [Abstract][Full Text] [Related]
33. Ipilimumab and craniotomy in patients with melanoma and brain metastases: a case series.
Jones PS; Cahill DP; Brastianos PK; Flaherty KT; Curry WT
Neurosurg Focus; 2015 Mar; 38(3):E5. PubMed ID: 25727227
[TBL] [Abstract][Full Text] [Related]
34. Ipilimumab in pretreated patients with unresectable or metastatic cutaneous, uveal and mucosal melanoma.
Alexander M; Mellor JD; McArthur G; Kee D
Med J Aust; 2014 Jul; 201(1):49-53. PubMed ID: 24999899
[TBL] [Abstract][Full Text] [Related]
35. Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma.
Fang P; Jiang W; Allen P; Glitza I; Guha N; Hwu P; Ghia A; Phan J; Mahajan A; Tawbi H; Li J
J Neurooncol; 2017 Jul; 133(3):595-602. PubMed ID: 28500560
[TBL] [Abstract][Full Text] [Related]
36. Survival of patients with melanoma brain metastasis treated with stereotactic radiosurgery and active systemic drug therapies.
Choong ES; Lo S; Drummond M; Fogarty GB; Menzies AM; Guminski A; Shivalingam B; Clarke K; Long GV; Hong AM
Eur J Cancer; 2017 Apr; 75():169-178. PubMed ID: 28236768
[TBL] [Abstract][Full Text] [Related]
37. Stereotactic radiosurgery for the treatment of melanoma and renal cell carcinoma brain metastases.
Lwu S; Goetz P; Monsalves E; Aryaee M; Ebinu J; Laperriere N; Menard C; Chung C; Millar BA; Kulkarni AV; Bernstein M; Zadeh G
Oncol Rep; 2013 Feb; 29(2):407-12. PubMed ID: 23151681
[TBL] [Abstract][Full Text] [Related]
38. Stereotactic radiosurgery combined with targeted/ immunotherapy in patients with melanoma brain metastasis.
Hadi I; Roengvoraphoj O; Bodensohn R; Hofmaier J; Niyazi M; Belka C; Nachbichler SB
Radiat Oncol; 2020 Feb; 15(1):37. PubMed ID: 32059731
[TBL] [Abstract][Full Text] [Related]
39. Treatment patterns and clinical outcomes for patients with melanoma and central nervous system metastases: A real-world study.
Tawbi H; To TM; Bartley K; Sadetsky N; Burton E; Haydu L; McKenna E
Cancer Med; 2022 Jan; 11(1):139-150. PubMed ID: 34874127
[TBL] [Abstract][Full Text] [Related]
40. Initial experience with combined BRAF and MEK inhibition with stereotactic radiosurgery for BRAF mutant melanoma brain metastases.
Patel BG; Ahmed KA; Johnstone PA; Yu HH; Etame AB
Melanoma Res; 2016 Aug; 26(4):382-6. PubMed ID: 26926151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]